Apr 6, 2016 by Brian FeroldiHere's Why Sarepta Therapeutics Jumped TodayAn investment firm issued a bullish note on the company's future and upped their price target.
Apr 6, 2016 by Brian Feroldi Pfizer vs. Allergan: Which Is the Better Breakup Buy?In the wake of the mega-merger deal being called off, which of these two pharma giants is the better value?
Apr 6, 2016 by Brian Feroldi, Dan Caplinger, Andrés Cardenal, Timothy Green, and George Budwell, PhD5 Best Dividend Stocks to Buy in AprilOur contributors think these five dividend-paying stocks are compelling opportunities right now.
Apr 6, 2016 by Brian FeroldiWhy TransEnterix Inc. Is Soaring TodayTraders are bidding up shares in anticipation of an FDA approval.
Apr 6, 2016 by Brian FeroldiCorcept Therapeutics Rose 18% in March. Here's Why.Credit an earnings report chock full of better-than-expected news, plus optimism about drugs in clinical trials, for investors' upbeat view on this small-cap biopharma.
Apr 5, 2016 by Brian FeroldiThis Amgen News Could Be a Game-Changer in Its Fight Against Sanofi and Regeneron PharmaceuticalsThe battle to supply the next generation of cholesterol-lowering drugs just took a major shift.
Apr 4, 2016 by Brian FeroldiWhy Shares of TherapeuticsMD Inc Are Soaring TodayMore details on a pivotal clinical trial mixed with a bullish analyst report send shares screaming higher.
Apr 3, 2016 by Brian FeroldiWill Social Security Raise My Benefits?Can retirees count on annual increases in their Social Security checks to help them meet their basic needs?
Apr 3, 2016 by Brian Feroldi, Sean Williams, Cory Renauer, Todd Campbell, Cheryl Swanson, and Kristine HarjesThis Could Be the Next Big Pharma BuyoutOur healthcare contributors think these five stocks might be on big pharma's shopping list.
Apr 2, 2016 by Brian FeroldiLast Week's Best Healthcare ETFIt was a terrific week to be a healthcare investor, but the performance of this one ETF was simply outstanding.
Apr 2, 2016 by Brian FeroldiThe Shocking List of Services Medicare Won't Pay ForYou might be shocked to learn about some of the coverage gaps that exist in regular Medicare.
Apr 1, 2016 by Brian FeroldiRegeneron Pharmaceuticals Inc Jumps on Positive Clinical DataShares are on the move after clinical data is released on a compound that holds blockbuster potential.
Apr 1, 2016 by Brian FeroldiWhy It's Been a Wild Few Days for Genocea Biosciences Inc.Shares are falling today, but let's keep it in perspective.
Apr 1, 2016 by Brian Feroldi, Jamal Carnette, CFA, and Daniel B. Kline3 Dividend Aristocrats We Will Never BuyWhile many Dividend Aristocrats are destined to become great long-term investments, our contributors think you should take a pass on these three stocks.
Mar 29, 2016 by Brian Feroldi, Tyler Crowe, Neha Chamaria, and Andrés Cardenal1 Stock I'm Watching, but Won't Buy YetOur contributors have these stocks on their radar, but they don't think they're buying candidates yet.
Mar 29, 2016 by Brian Feroldi, Keith Speights, and Cory Renauer3 Biotech Stocks You Don't Have to BabysitLooking for a biotech stock that doesn't require constant monitoring? Our contributors suggest that you take a closer look at these three stocks.
Mar 28, 2016 by Brian FeroldiLast Week's Best Healthcare ETF It was a good week for healthcare ETFs, but this one fund put up a stellar performance.
Mar 27, 2016 by Brian Feroldi3 Stocks With Better Dividends Than American Express CompanyAmerican Express' dividend yield is near a five-year high, but income-focused investors might want to look at these three dividend stocks instead.
Mar 26, 2016 by Brian FeroldiCan My Spouse Claim My Social Security Benefits?Learning all of the details that govern the Social Security spousal benefit can be a bit complex, so here's a look at some of the basics that all retirees should know.
Mar 26, 2016 by Brian Feroldi, Sean Williams, and Cheryl Swanson3 Healthcare Stocks You Don't Have to BabysitThe healthcare sector tends to be recession-resistant, which makes it a good place to find low-risk stocks.
